New studies into retatrutide, a dual agonist for GLP-1 and GIP receptors, are revealing promising results in addressing excess mass and diabetes 2 condition. Animal information suggest a distinct mechanism contributing https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/